Amryt Pharma

Biopharma stocks go back to bleak
EP Vantage
Thu, 04/6/23 - 09:51 am
Albireo Pharma
Amryt Pharma
Apellis Pharmaceuticals
AstraZeneca
BridgeBio
Novo Nordisk
Pfizer
Protagonist Therapeutics
Provention Bio
Reata Pharmaceuticals
Regeneron
Sanofi
Seagen
Trio of biotech buyouts jumpstarts J.P. Morgan healthcare meeting
BioPharma Dive
Mon, 01/9/23 - 10:43 am
JPMHC 2023
M&A
AstraZeneca
CinCor
Ipsen
Albireo
Chiesi Farmaceutici
Amryt Pharma
Italy's Chiesi Farmaceutici to buy Amryt Pharma in a $1.48 billion deal
Reuters
Sun, 01/8/23 - 10:17 pm
Chiesi Farmaceutici
M&A
Amryt Pharma
FDA regulatory roundup: two approvals, three rejections & one clinical hold
MedCity News
Sun, 03/6/22 - 11:08 pm
FDA
JNJ
CTI BioPharma
Gilead Sciences
Amryt Pharma
Reata Pharmaceuticals
Amryt Pharma Shares Tumble After FDA Rejects Oleogel-S10 Application
Marketwatch
Mon, 02/28/22 - 11:29 am
Amryt Pharma
FDA
Oleogel-S10
epidermolysis bullosa
The 20 most expensive pharmacy drugs in the U.S. in 2020, from fallen blockbusters to new orphan meds
Fierce Pharma
Fri, 02/14/20 - 05:11 pm
drug pricing
Amryt Pharma
Myalept
Agios Pharmaceuticals
Tibsovo
Amryt buys Aegerion via bankruptcy, adding sales to support R&D
Fierce Biotech
Wed, 09/25/19 - 09:52 am
Amryt Pharma
Aegerion
M&A
R&D
bankruptcy
AP101
2018 in review: How patient centricity led to new drugs that tackle unmet need
Pharmaforum
Mon, 12/17/18 - 09:22 am
patients
drug development
Sunovion
Sangamo
Amryt Pharma
Two biotechs to keep an eye on
GoinPharma
Mon, 06/18/18 - 06:35 pm
Amryt Pharma
Eloxx Pharmaceuticals
lomitapide
ELX-02